These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 31976826)

  • 1. Higher Baseline ADCC Responses in Chronic Nonprogressive HIV Infection Are Associated with Reduced HIV Burden in Later Course of Disease.
    Talathi S; Bagul R; Ghate M; Kulkarni S; Thakar M
    Viral Immunol; 2020 Mar; 33(2):77-85. PubMed ID: 31976826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Early Antibody-Dependent Cell-Mediated Cytotoxicity Response Is Associated With Lower Viral Set Point in Individuals With Primary HIV Infection.
    Chen X; Lin M; Qian S; Zhang Z; Fu Y; Xu J; Han X; Ding H; Dong T; Shang H; Jiang Y
    Front Immunol; 2018; 9():2322. PubMed ID: 30356637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brief Report: The Anti-HIV-1 ADCC-Mediating Antibodies From Cervicovaginal Secretions of HIV-Infected Women Have an Ability to Mediate Lysing of Autologous CD4+ HIV-Infected Cells.
    Dhande J; Angadi M; Murugavel KG; Poongulali S; Nandagopal P; Vignesh R; Ghate M; Kulkarni S; Thakar M
    J Acquir Immune Defic Syndr; 2018 Oct; 79(2):277-282. PubMed ID: 30211779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific antibody-dependent cellular cytotoxicity responses associated with slow progression of HIV infection.
    Wren LH; Chung AW; Isitman G; Kelleher AD; Parsons MS; Amin J; Cooper DA; ; Stratov I; Navis M; Kent SJ
    Immunology; 2013 Feb; 138(2):116-23. PubMed ID: 23173935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of antibodies that mediate HIV type 1 gp120 antibody-dependent cell-mediated cytotoxicity in asymptomatic HIV type 1-positive men and women.
    Mata MM; Iwema JR; Dell S; Neems L; Jamieson BD; Phair J; Cohen MH; Anastos K; Baum LL
    AIDS Res Hum Retroviruses; 2014 Jan; 30(1):50-7. PubMed ID: 23972002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-specific CD4-induced Antibodies Mediate Broad and Potent Antibody-dependent Cellular Cytotoxicity Activity and Are Commonly Detected in Plasma From HIV-infected humans.
    Williams KL; Cortez V; Dingens AS; Gach JS; Rainwater S; Weis JF; Chen X; Spearman P; Forthal DN; Overbaugh J
    EBioMedicine; 2015 Oct; 2(10):1464-77. PubMed ID: 26629541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Env-Specific IgA from Viremic HIV-Infected Subjects Compromises Antibody-Dependent Cellular Cytotoxicity.
    Ruiz MJ; Ghiglione Y; Falivene J; Laufer N; Holgado MP; Socías ME; Cahn P; Sued O; Giavedoni L; Salomón H; Gherardi MM; Rodríguez AM; Turk G
    J Virol; 2016 Jan; 90(2):670-81. PubMed ID: 26491172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum and effector-cell antibody-dependent cellular cytotoxicity (ADCC) activity remains high during human immunodeficiency virus (HIV) disease progression.
    Ojo-Amaize E; Nishanian PG; Heitjan DF; Rezai A; Esmail I; Korns E; Detels R; Fahey J; Giorgi JV
    J Clin Immunol; 1989 Nov; 9(6):454-61. PubMed ID: 2576558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Combination Antiretroviral Therapy on HIV-1-specific Antibody-Dependent Cellular Cytotoxicity Responses in Subtype B- and Subtype C-Infected Cohorts.
    Madhavi V; Kulkarni A; Shete A; Lee WS; Mclean MR; Kristensen AB; Ghate M; Wines BD; Hogarth PM; Parsons MS; Kelleher A; Cooper DA; Amin J; Emery S; Thakar M; Kent SJ;
    J Acquir Immune Defic Syndr; 2017 Jul; 75(3):345-353. PubMed ID: 28346319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD4- and Time-Dependent Susceptibility of HIV-1-Infected Cells to Antibody-Dependent Cellular Cytotoxicity.
    Lee WS; Prévost J; Richard J; van der Sluis RM; Lewin SR; Pazgier M; Finzi A; Parsons MS; Kent SJ
    J Virol; 2019 May; 93(10):. PubMed ID: 30842324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody-Dependent Cellular Cytotoxicity-Competent Antibodies against HIV-1-Infected Cells in Plasma from HIV-Infected Subjects.
    Dupuy FP; Kant S; Barbé A; Routy JP; Bruneau J; Lebouché B; Tremblay C; Pazgier M; Finzi A; Bernard NF
    mBio; 2019 Dec; 10(6):. PubMed ID: 31848282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ADCC-mediating non-neutralizing antibodies can exert immune pressure in early HIV-1 infection.
    Mielke D; Bandawe G; Zheng J; Jones J; Abrahams MR; Bekker V; Ochsenbauer C; Garrett N; Abdool Karim S; Moore PL; Morris L; Montefiori D; Anthony C; Ferrari G; Williamson C
    PLoS Pathog; 2021 Nov; 17(11):e1010046. PubMed ID: 34788337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NK cell function and antibodies mediating ADCC in HIV-1-infected viremic and controller patients.
    Johansson SE; Rollman E; Chung AW; Center RJ; Hejdeman B; Stratov I; Hinkula J; Wahren B; Kärre K; Kent SJ; Berg L
    Viral Immunol; 2011 Oct; 24(5):359-68. PubMed ID: 21958370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody-Dependent Cellular Cytotoxicity (ADCC)-Mediating Antibodies Constrain Neutralizing Antibody Escape Pathway.
    Mielke D; Bandawe G; Pollara J; Abrahams MR; Nyanhete T; Moore PL; Thebus R; Yates NL; Kappes JC; Ochsenbauer C; Garrett N; Abdool Karim S; Tomaras GD; Montefiori D; Morris L; Ferrari G; Williamson C
    Front Immunol; 2019; 10():2875. PubMed ID: 31921139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pol as a target for antibody dependent cellular cytotoxicity responses in HIV-1 infection.
    Isitman G; Chung AW; Navis M; Kent SJ; Stratov I
    Virology; 2011 Mar; 412(1):110-6. PubMed ID: 21269655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible beneficial effects of neutralizing antibodies and antibody-dependent, cell-mediated cytotoxicity in human immunodeficiency virus infection.
    Sawyer LA; Katzenstein DA; Hendry RM; Boone EJ; Vujcic LK; Williams CC; Zeger SL; Saah AJ; Rinaldo CR; Phair JP
    AIDS Res Hum Retroviruses; 1990 Mar; 6(3):341-56. PubMed ID: 1971182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-Specific Antibody-Dependent Cellular Cytotoxicity (ADCC) -Mediating Antibodies Decline while NK Cell Function Increases during Antiretroviral Therapy (ART).
    Jensen SS; Fomsgaard A; Borggren M; Tingstedt JL; Gerstoft J; Kronborg G; Rasmussen LD; Pedersen C; Karlsson I
    PLoS One; 2015; 10(12):e0145249. PubMed ID: 26696395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody-Dependent Cellular Cytotoxicity Activity of Effector Cells from HIV-Infected Elite and Viral Controllers.
    Isitman G; Lisovsky I; Tremblay-McLean A; Kovacs C; Harris M; Routy JP; Bruneau J; Wainberg MA; Tremblay C; Bernard NF
    AIDS Res Hum Retroviruses; 2016; 32(10-11):1079-1088. PubMed ID: 27499379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequencies of Circulating Th1-Biased T Follicular Helper Cells in Acute HIV-1 Infection Correlate with the Development of HIV-Specific Antibody Responses and Lower Set Point Viral Load.
    Baiyegunhi O; Ndlovu B; Ogunshola F; Ismail N; Walker BD; Ndung'u T; Ndhlovu ZM
    J Virol; 2018 Aug; 92(15):. PubMed ID: 29793949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. gp120-directed antibody-dependent cellular cytotoxicity as a major determinant of the rate of decline in CD4 percentage in HIV-1 disease.
    Skowron G; Cole BF; Zheng D; Accetta G; Yen-Lieberman B
    AIDS; 1997 Dec; 11(15):1807-14. PubMed ID: 9412698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.